Status:

RECRUITING

Vitamin C Administration and Triglycerides Level in Critical Care Patients

Lead Sponsor:

Meir Medical Center

Conditions:

Hypertriglyceridemia

Eligibility:

All Genders

18-99 years

Brief Summary

Vitamin C (ascorbic acid) is a water-soluble vitamin with antioxidant properties. Previous studies showed that the administration of vitamin C was associated with decreased triglyceride (TG) levels in...

Eligibility Criteria

Inclusion

  • Inclusion Criteria: patients aged 18-99 who were admitted to the general intensive care unit from January 2017 to December 2023, and who were treated with intravenous vitamin C. The control group will include patients with the same characteristics who were not treated with vitamin C.
  • Exclusion criteria: patients who did not meet the above conditions or for whom data were missing.
  • \-
  • \-

Exclusion

    Key Trial Info

    Start Date :

    May 1 2024

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    February 1 2027

    Estimated Enrollment :

    2000 Patients enrolled

    Trial Details

    Trial ID

    NCT06206759

    Start Date

    May 1 2024

    End Date

    February 1 2027

    Last Update

    May 11 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Meir Medical Center

    Kfar Saba, Israel